Churg-Strauss syndrome epidemiology and demographics
Churg-Strauss syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Churg-Strauss syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
Churg-Strauss syndrome epidemiology and demographics in the news |
Blogs on Churg-Strauss syndrome epidemiology and demographics |
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.[1][2]
Incidence
The incidence of Eosinophilic granulomatosis with polyangiitis range from 0.5 to 6.8 per million persons per year.[3]
Demographics
Age
The mean age of diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.[4]
Gender
In general there is no gender predeliction to Eosinophilic granulomatosis with polyangiitis.
Race
In general there is no racial predilictio to eosinophilic granulomatosis with polyangiitis.
References
- ↑ 1.0 1.1 Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R (June 2005). "Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective". J. Rheumatol. 32 (6): 1076–80. PMID 15940771.